Patrocinado
US & Japan Trends Shape EU Gene-Therapy Adoption in SCD
  Recent market studies indicate that Germany Europe’s leading SCD market achieved revenue of USD 142.6 million in 2023, with projections of USD 362.7 million by 2030, reflecting a 14.3% CAGR. Across Europe, the United Kingdom is forecasted to reach USD 450.4 million by 2030. The rise in patient awareness, genetic screening, and improved delivery of care is underpinning these gains....
0 Comentários 0 Compartilhamentos 35 Visualizações 0 Anterior
Patrocinado
Patrocinado
Patrocinado